Valuation: OrganiGram Holdings Inc

Market Cap 241M 174M 149M 140M 128M 16.65B 245M 1.65B 645M 8.35B 654M 640M 27.61B P/E 2026 *
2.12x
P/E 2027 * 21.4x
Enterprise Value 241M 174M 149M 140M 128M 16.65B 245M 1.65B 645M 8.35B 654M 640M 27.61B EV / Sales 2026 *
0.69x
EV / Sales 2027 * 0.53x
Free-Float
69.79%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 14/01/2026
Director of Finance/CFO - 07/01/2024
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 65 28/03/2018
Director/Board Member 56 16/12/2018
Director/Board Member 70 16/12/2018
Change 5-day change 1-year change 3-year change Capi.($)
+4.72%+2.95% - - 174M
-0.57%+4.66%-9.62%+183.13% 319M
-4.09%-6.29%-20.77%-19.21% 174M
+1.02%0.00%+5.32%+83.33% 140M
-4.65%-4.65%-26.79%-25.45% 87.38M
0.00%+3.70%+3.70%+21.74% 50.18M
Average -0.60%+0.51%-9.63%+48.71% 154.21M
Weighted average by Cap. -0.36%+0.86%-10.50%+85.14%

Financials

2026 *2027 *
Net sales 350M 253M 217M 203M 186M 24.19B 356M 2.39B 937M 12.13B 950M 930M 40.11B 458M 331M 284M 266M 244M 31.68B 466M 3.13B 1.23B 15.89B 1.24B 1.22B 52.54B
Net income 128M 92.84M 79.64M 74.37M 68.23M 8.87B 130M 878M 344M 4.45B 349M 341M 14.72B 8.1M 5.86M 5.03M 4.69M 4.31M 560M 8.23M 55.4M 21.69M 281M 22.01M 21.53M 929M
Net Debt - -
Logo OrganiGram Holdings Inc
Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-